Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
For the estimated 70% of eligible adults who have never filled a GLP-1 prescription, this is a meaningful change in what the treatment landscape looks like
349,350 The ongoing phase 3 study ELAINE-3 (NCT05696626) aims to evaluate the effects of abemaciclib combined with either lasofoxifene or fulvestrant in patients with ESR1-mutated, locally advanced or metastatic ER+/HER2 breast cancer
Physician-Led, On-Site Care: Patients receive Semaglutide therapy in a physician-directed medspa where dose adjustments, safety assessments, and supportive recommendations (such as nutrition and activity guidance) are handled in real time by medically trained providers
Patients should compare total cost across alternatives, including modern combination protocols, when planning a 6 to 12 month treatment cycle
US$ 23.09
US$ 28.17
US$ 28.33
US$ 22.38
